Scholarly Index
Stuart J. Schnitt
Beth Israel Deaconess Medical Center; 45,838 total citations; 482 total publications; best world rank #3
Beth Israel Deaconess Medical Center
45,838Total citations
482Total publications
112H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer and Skin Lesions | Lifetime | 3 | US 2 | 99.88 |
| Breast Lesions and Carcinomas | Lifetime | 4 | US 3 | 99.92 |
| Breast Cancer Treatment Studies | Lifetime | 14 | US 7 | 99.92 |
| HER2/EGFR in Cancer Research | Lifetime | 85 | US 44 | 99.57 |
| AI in cancer detection | Lifetime | 67 | US 28 | 99.07 |
| Cancer Genomics and Diagnostics | Lifetime | 280 | US 172 | 99.44 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 205 | US 105 | 98.51 |
| Breast Implant and Reconstruction | Lifetime | 124 | US 83 | 98.17 |
| Cancer Cells and Metastasis | Lifetime | 556 | US 248 | 97.71 |
| Global Cancer Incidence and Screening | Lifetime | 399 | US 214 | 98.02 |
| BRCA gene mutations in cancer | Lifetime | 496 | US 264 | 96.73 |
| Advanced Breast Cancer Therapies | Lifetime | 572 | US 252 | 95.53 |
| Male Breast Health Studies | Lifetime | 200 | US 83 | 81.92 |
| Breast Cancer Treatment Studies | 2021-2025 | 235 | US 78 | 97.34 |
| Breast Lesions and Carcinomas | 2021-2025 | 77 | US 20 | 95.84 |
| Cancer and Skin Lesions | 2021-2025 | 90 | US 38 | 91.40 |
| HER2/EGFR in Cancer Research | 2021-2025 | 551 | US 197 | 91.04 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 960 | US 220 | 73.41 |